[1]
|
J. Kanwar, M. Taskeen, I. Mohammad, C. Huo, T. H. Chan and Q. P. Dou, “Recent Advances on Tea Polyphenols,” A Frontiers in Bioscience (Elite Edition), Vol. 4, 2012, pp. 111-131. Uhttp://dx.doi.org/10.2741/363U
|
[2]
|
C. S. Yang, X. Wang, G. Lu and S. C. Picinich, “Cancer Prevention by Tea: Animal Studies, Molecular Mechanisms and Human Relevance,” Nature Reviews Cancer, Vol. 9, No. 6, 2009, pp. 429-439. Uhttp://dx.doi.org/10.1038/nrc2641U
|
[3]
|
Z. Hou, S. Sang, H. You, M. J. Lee, J. Hong, K. V. Chin and C. S. Yang, “Mechanism of Action of (-)-Epigallocatechin-3-Gallate: Auto-Oxidation Dependent Inactivation of Epidermal Growth Factor Receptor and Direct Effects on Growth Inhibition in Human Oesophageal Cancer KYSE 150 Cells,” Cancer Research, Vol. 65, No. 17, 2005, pp. 8049-8056.
|
[4]
|
Y. Shirakami, M. Shimizu, H. Tsurumi, Y. Hara, T. Tanaka and H. Moriwaki, “EGCG and Polyphenon E Attenuate Inflammation-related Mouse Colon Carcinogenesis Induced by AOM plus DDS,” Molecular Medicine Reports, Vol. 1, No. 3, 2008, pp. 355-361.
|
[5]
|
M. Shimizu, S. Adachi, M. Masuda, O. Kozawa and H. Moriwaki, “Cancer Chemoprevention with Green Tea Catechins by Targeting Receptor Tyrosine Kinases,” Molecular Nutrition and Food Research, Vol. 55, No. 6, 2011, pp. 832-843. Uhttp://dx.doi.org/10.1002/mnfr.201000622U
|
[6]
|
T. Ohishi, Y. Kishimoto, N. Miura, G. Shiota, T. Kohri, Y. Hara, J. Hasegawa and M. Isemura, “Synergistic Effects of (-)-Epigallocatechin Gallate with Sulindac Against Colon Carcinogenesis of Rats Treated with Azoxymethane,” Cancer Letters, Vol. 177, No. 1, 2002, pp. 49-56. Uhttp://dx.doi.org/10.1016/S0304-3835(01)00767-4U
|
[7]
|
A. H. Schönthal, “Adverse Effects of Concentrated Green Tea Extracts,” Molecular Nutrition and Food Research, Vol. 55, No. 6, 2011, pp. 874-885. Uhttp://dx.doi.org/10.1002/mnfr.201000644U
|
[8]
|
J. D. Lambert, M. J. Kennett, S. Sang, K. R. Reuhl, J. Ju and C. S. Yang, “Hepatotoxicity of High Oral Dose (-)Epigallocatechin-3-Gallate in Mice,” Food and Chemical Toxicology, Vol. 48, No. 1, 2010, pp. 409-416. Uhttp://dx.doi.org/10.1016/j.fct.2009.10.030U
|
[9]
|
A. Jain, C. Manghani, S. Kohli, D. Nigam and V. Rani, “Tea and Human Health: The Dark Shadows,” Toxicology Letters, Vol. 221, No 1, 2013, pp. 82-87. Uhttp://dx.doi.org/10.1016/j.toxlet.2013.04.010U
|
[10]
|
F. Stirpe, “Ribosome-Inactivating Proteins,” Toxicon, Vol. 44, No. 4, 2004, pp. 371-383. Uhttp://dx.doi.org/10.1016/j.toxicon.2004.05.004U
|
[11]
|
T. Girbés, J. M. Ferreras, F. J. Arias and F. Stirpe, “Description, Distribution, Activity and Phylogenetic Relationship of Ribosome-Inactivating Proteins in Plants, Fungi and Bacteria,” Mini Reviews in Medicinal Chemistry, Vol. 4, No. 5, 2004, pp. 461-476. Uhttp://dx.doi.org/10.2174/1389557043403891U
|
[12]
|
T. B. Ng, J. H. Wong and H. Wang, “Recent Progress in Research on Ribosome Inactivating Proteins,” Current Protein and Peptide Science, Vol. 11, No. 1, 2010, pp. 37-53. Uhttp://dx.doi.org/10.2174/138920310790274662U
|
[13]
|
W. J. Peumans and E. J. Van Damme, “Lectins as Plant Defence Proteins,” Plant Physiology, Vol. 109, No. 2, 1995, pp. 347-352. Uhttp://dx.doi.org/10.1104/pp.109.2.347U
|
[14]
|
T. Girbés, C. de Torre, R. Iglesias, J. M. Ferreras and E. Méndez, “RIP for Viruses,” Nature, Vol. 379, 1996, pp. 777-778. Uhttp://dx.doi.org/10.1038/379777b0U
|
[15]
|
G. Corrado, P. Delli Bovi, R. Ciliento, L. Gaudio, A. Di Maro, S. Aceto, M. Lorito and R. Rao, “Inducible Expression of a Phytolacca heterotepala Ribosome-Inactivating Protein Leads to Enhanced Resistance against Major Fungal Pathogens in Tobacco,” Phytopathology, Vol. 95, No. 2, 2005, pp. 206-215. Uhttp://dx.doi.org/10.1094/PHYTO-95-0206U
|
[16]
|
L. Polito, M. Bortolotti, D. Mercatelli, M. G. Battelli and A. Bolognesi, “Saporin-S6: A Useful Tool in Cancer Therapy,” Toxins (Basel), Vol. 5, No. 10, 2013, pp. 1698-1722. Uhttp://dx.doi.org/10.3390/toxins5101698U
|
[17]
|
S. V. Govindan and D. M. Goldenberg, “Designing Immunoconjugates for Cancer Therapy,” Expert Opinion on Biological Therapy, Vol. 12, No. 7, 2012, pp. 873-890. Uhttp://dx.doi.org/10.1517/14712598.2012.685153U
|
[18]
|
J. M. Ferreras, L. Citores, R. Iglesias, P. Jiménez and T. Girbés, “Use of Ribosome-inactivating Proteins from Sambucus for the Construction of Immunotoxins and Conjugates for Cancer Therapy,” Toxins (Basel), Vol. 3, No. 5, 2011, pp. 420-441. Uhttp://dx.doi.org/10.3390/toxins3050420U
|
[19]
|
J. M. Ferreras, L. Citores, R. Iglesias, P. Jiménez, A. M. Souza, M. Gayoso and T. Girbés, “Occurrence and New Procedure of Preparation of Nigrin, an Antirribosomal Lectin Present in Elderberry Bark,” Food Research International, Vol. 44, No. 9, 2011, pp. 2798-2805. Uhttp://dx.doi.org/10.1016/j.foodres.2011.06.004U
|
[20]
|
P. Jiménez, J. Tejero, P. Cabrero, D. Cordoba-Diaz and T. Girbes, “Differential Sensitivity of D-Galactose Binding Lectins from Fruits of Dwarf Elder (Sambucus ebulus L.) to a Simulated Gastric Fluid,” Food Chemistry, Vol. 136, No. 2, 2013, pp. 794-902. Uhttp://dx.doi.org/10.1016/j.foodchem.2012.09.011U
|
[21]
|
M. G. Battelli, L. Citores, L. Buonamici, J. M. Ferreras, F. M. de Benito, F. Stirpe and T. Girbés, “Toxicity and Cytotoxicity of Nigrin b, a Two-Chain Ribosome-Inactivating Protein from Sambucus nigra: a Comparison with Ricin,” Archives of Toxicology, Vol. 71, No. 6, 1997, pp. 360-364. Uhttp://dx.doi.org/10.1007/s002040050399U
|
[22]
|
M. J. Gayoso, R. Muñoz, Y. Arias, R. Villar, M. A. Rojo, P. Jiménez, J. M. Ferreras, I. Aránguez and T. Girbés, “Specific Dose-Dependent Damage of Lieberkühn Crypts Promoted by Large Doses of Type 2 Ribosome-Inactivating Protein Nigrin b Intravenous Injection to Mice,” Toxicology and Applied Pharmacology, Vol. 207, No. 2, 2005, pp. 138-146. Uhttp://dx.doi.org/10.1016/j.taap.2004.12.011U
|
[23]
|
P. Jiménez, D. Cordoba-Diaz, P. Cabrero, M. Aracil, M. J. Gayoso, M. Garrosa, M. Cordoba-Diaz and T. Girbés, “Plasma Accumulation of Vitamin B6 from an Oral Dose in a New Gut In-jury-Regeneration Reversible Mouse Model,” Food and Nutrition Sciences, Vol. 4, 2013, pp. 908-917. Uhttp://dx.doi.org/10.4236/fns.2013.49118U
|
[24]
|
O. Fumiko, K. Takashi, O. Takahide and F. Yukihiko, “Composition for Strengthening Acid Resistant of Teeth,” US Patent No. 5470565, 1995.
|
[25]
|
T. Girbés, L. Citores, J. M. Ferreras, M. A. Rojo, R. Iglesias, R. Muñoz, F. J. Arias, M. Calonge, J. R. García and E. Méndez, “Isolation and Partial Characterization of Nigrin b, a Non-Toxic Novel Type 2 Ribosome-Inactivating Protein from the Bark of Sambucus nigra L,” Plant Molecular Biology, Vol. 22, No. 6, 1993, pp. 1181-1186. Uhttp://dx.doi.org/10.1007/BF00028990U
|
[26]
|
A. Ui, S. Kuriyama, M. Kakizaki, T. Sone, N. Nakaya, K. Ohmori-Matsuda, A. Hozawa, Y. Nishino and I. Tsuji, “Green Tea Consumption and the Risk of Liver Cancer in Japan: The Ohsaki Cohort Study,” Cancer Causes and Control, Vol. 20, No. 10, 2009, pp. 1939-1945. Uhttp://dx.doi.org/10.1007/s10552-009-9388-xU
|
[27]
|
J. Frank, T. W. George, J. K. Lodge, A. M. RodriguezMateos, J. P. E. Spencer, A. M. Minihane and G. Rimbach, “Daily Consumption of an Aqueous Green Tea Extract Supplement Does Not Impair Liver Function or Alter Cardiovascular Disease Risk Biomarkers in Healthy Men,” The Journal of Nutrition, Vol. 139, No. 1, 2009, pp. 58-62. Uhttp://dx.doi.org/10.3945/jn.108.096412U
|
[28]
|
F. Danesi, M. Di Nunzio, E. Boschetti and A. Bordoni, “Green Tea Extract Selectively Acti-vates Peroxisome Proliferator-Activated Receptor Beta/Delta in Cultured Cardiomyocytes,” British Journal of Nutrition, Vol. 101, No. 12, 2009, pp. 1736-1739. Uhttp://dx.doi.org/10.1017/S0007114508145871U
|
[29]
|
M. Schmidt, H. J. Schmitz, A. Baumgart, D. Guédon, M. I. Netsch, M. H. Kreuter, C. B. Schmidlin and D. Schrenk, “Toxicity of Green Tea Extracts and Their Constituents in Rat Hepatocytes in Primary Culture,” Food and Chemical Toxicology, Vol. 43, No. 2, 2005, pp. 307-314. Uhttp://dx.doi.org/10.1016/j.fct.2004.11.001U
|
[30]
|
A. Javaid and H. L. Bonkovsky, “Hepatotoxicity Due to Extracts of Chinese Green Tea (Camellia sinensis): a Growing Concern,” Journal of Hepatology, Vol. 45, No. 2, 2006, pp. 334-335. Uhttp://dx.doi.org/10.1016/j.jhep.2006.05.005U
|
[31]
|
X. Jin, R. H. Zheng and Y. M. Li, “Green Tea Consumption and Liver Disease: A Systematic Review,” Liver International, Vol. 28, No. 7, 2008, pp. 990-996. Uhttp://dx.doi.org/10.1111/j.1478-3231.2008.01776.xU
|
[32]
|
C. Bunchorntavakul and K. R. Reddy, “Review Article: Herbal and Dietary Supplement Hepatotoxicity,” Alimentary Pharmacology & Therapeutics, Vol. 37, No. 1, 2013, pp. 3-17. http://dx.doi.org/10.1111/apt.12109U
|
[33]
|
G. Mazzanti, F. Menniti-Ippolito, P. A. Moro, F. Cassetti, R. Raschetti, C. Santuccio and S. Mastrangelo, “Hepatotoxicity from Green Tea: A Review of the Literature and Two Unpublished Cases,” European Journal of Clinical Pharmacology, Vol. 65, No. 4, 2009, pp. 331-341. Uhttp://dx.doi.org/10.1007/s00228-008-0610-7U
|